Human Pathology
Volume 41, Issue 2 , Pages 281-285 , February 2010

Any proportion of ductal adenocarcinoma in radical prostatectomy specimens predicts extraprostatic extension

  • Hemamali Samaratunga, FRCPA

      Affiliations

    • Aquesta Pathology, Brisbane, Queensland, 4064 Australia
    • Corresponding Author InformationCorresponding author.
  • ,
  • David Duffy, MBBS

      Affiliations

    • Queensland Institute of Medical Research, Brisbane, Queensland, 4064 Australia
  • ,
  • John Yaxley, FRACS (Urol)

      Affiliations

    • Royal Brisbane Hospital, Brisbane, Queensland, 4064 Australia
  • ,
  • Brett Delahunt, MD FRCPA

      Affiliations

    • Department of Pathology and Molecular Medicine, Wellington School of Medicine and Health Sciences, University of Otago–Wellington, Wellington, 6242 New Zealand

Received 9 July 2009 ,Revised 12 August 2009 ,Accepted 17 August 2009.

References 

  1. Samaratunga H, Delahunt B. Ductal adenocarcinoma of the prostate: current opinion and controversies. Quant Anal Histol Cytol. 2008;30:237–246
  2. Millar EK, Sharma NK, Lessells AM. Ductal (endometrioid) adenocarcinoma of the prostate: a clinicopathological study of 16 cases. Histopathology. 1996;29:11–19
  3. Epstein JI, Woodruff JM. Adenocarcinoma of the prostate with endometrioid features: a light microscopic and immunohistochemical study of 10 cases. Cancer. 1986;57:111–119
  4. Brinker DA, Potter SR, Epstein JI. Ductal adenocarcinoma of the prostate diagnosed on needle biopsy; correlation with clinical and radical prostatectomy findings and progression. Am J Surg Pathol. 1999;23:1471–1479
  5. Christensen WN, Steinberg WN, Walsh PC, et al. Prostatic duct adenocarcinoma: findings on radical prostatectomy. Cancer. 1991;67:2118–2124
  6. Ro JY, Ayala AG, Wishnow KI, et al. Prostatic duct adenocarcinoma with endometrioid features: immunohistochemical and electron microscopic features. Semin Diagn Pathol. 1988;5:301–311
  7. Yang XJ, Cheng L, Helpap B, Samaratunga H. Ductal adenocarcinoma. In:  Eble JN,  Sauter GI,  Epstein JI,  Sesterhenn IA editor. Pathology and genetics: tumors of the urinary system and male genital organs. WHO classification of tumors. Lyon, France: IARC Press; 2004;p. 199–201
  8. Chen ME, Johnston D, Reyes AO, et al. A streamlined three-dimensional volume estimation method accurately classifies prostate tumours by volume. Am J Surg Pathol. 2003;27:1291–1295
  9. Epstein JI, Allsbrook WC, Amin MB, et al. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostate Cancer. Am J Surg Pathol. 2005;29:1228–1242
  10. R Development Core Team. 2006 [on line] R: A language and environment for statistical computing. R Foundation for Statistical Computing; Vienna, Austria. ISBN 3-900051-07-0, available at http://www.R-project.org. Accessed 15 June 2006.
  11. Bostwick DG, Kindrachuk RW, Rouse RV. Prostatic adenocarcinoma with endometrioid features. Clinical, pathological and ultrastructural findings. Am J Surg Pathol. 1985;9:595–609
  12. Green LF, Farrow GM, Ravits JM, Tomera FM. Prostatic adenocarcinoma of ductal origin. J Urol. 1979;121:303–305
  13. Dube VE, Farrow GM, Greene LF. Prostatic adenocarcinoma of ductal origin. Cancer. 1973;32:402–409
  14. Bock BJ, Bostwick DG. Does prostatic ductal adenocarcinoma exist?. Am J Surg Pathol. 1999;23:781–785
  15. Gong Y, Caraway N, Stuart J, Staerkel G. Metastatic ductal adenocarcinoma of the prostate: cytologic features and clinical findings. Am J Clin Pathol. 2006;126:302–309
  16. Copeland JN, Amin MB, Humphrey PA, Tamboli P, Ro JY, Gal AA. The morphological spectrum of metastatic prostatic adenocarcinoma to the lung: special emphasis on histologic features overlapping with other pulmonary neoplasms. Am J Clin Pathol. 2002;117:552–557
  17. Tu SM, Reyes A, Maa A, et al. Prostatic carcinoma with testicular or penile metastases. Clinical, pathologic, and immunohistochemical features. Cancer. 2002;94:2610–2617
  18. Humphrey PA, Baty J, Keetch DW. Relationship between serum prostate specific antigen, needle biopsy findings and histopathologic features of prostatic carcinoma in radical prostatectomy tissues. Cancer. 1995;75:1842–1849
  19. Djavan B, Kadensky K, Klopukh B, et al. Gleason scores from prostate biopsies obtained with 18-gauge biopsy needles poorly predict Gleason scores of radical prostatectomy specimens. Eur Urol. 1998;33:261–270

PII: S0046-8177(09)00297-4

doi: 10.1016/j.humpath.2009.08.010

Human Pathology
Volume 41, Issue 2 , Pages 281-285 , February 2010